Cargando…

Predicting Low-Risk Prostate Cancer from Transperineal Saturation Biopsies

Introduction. To assess the performance of five previously described clinicopathological definitions of low-risk prostate cancer (PC). Materials and Methods. Men who underwent radical prostatectomy (RP) for clinical stage ≤T2, PSA <10 ng/mL, Gleason score <8 PC, diagnosed by transperineal temp...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Leeuwen, Pim J., Siriwardana, Amila, Roobol, Monique, Ting, Francis, Nieboer, Daan, Thompson, James, Delprado, Warick, Haynes, Anne-Marie, Brenner, Phillip, Stricker, Phillip
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4842366/ https://www.ncbi.nlm.nih.gov/pubmed/27148459 http://dx.doi.org/10.1155/2016/7105678

Ejemplares similares

Assessment of the Performance of Magnetic Resonance Imaging/Ultrasound Fusion Guided Prostate Biopsy against a Combined Targeted Plus Systematic Biopsy Approach Using 24-Core Transperineal Template Saturation Mapping Prostate Biopsy
por: Ting, Francis, et al.
Publicado: (2016)

Transperineal biopsy of the prostate in a patient post abdominoperineal resection
por: Amin, Amer, et al.
Publicado: (2019)

The relationship between biochemical recurrence and number of lymph nodes removed during surgery for localized prostate cancer
por: Doan, Paul, et al.
Publicado: (2023)

Diagnostic accuracy of magnetic resonance-guided prostate biopsy and template-guided transperineal saturation biopsy
por: Zhou, Yi, et al.
Publicado: (2018)

Prostate cancer detection rate in men undergoing transperineal template‐guided saturation and targeted prostate biopsy
por: Kaufmann, Basil, et al.
Publicado: (2021)

Personalized Decision Making for Biopsies in Prostate Cancer Active Surveillance Programs
por: Tomer, Anirudh, et al.
Publicado: (2019)

Identifying Risk Factors for MRI-Invisible Prostate Cancer in Patients Undergoing Transperineal Saturation Biopsy
por: Artiles Medina, Alberto, et al.
Publicado: (2021)

Head-to-head comparison of prostate cancer risk calculators predicting biopsy outcome
por: Pereira-Azevedo, Nuno, et al.
Publicado: (2018)

Hundred years of transperineal prostate biopsy
por: Schmeusser, Benjamin, et al.
Publicado: (2022)

Reduced sensitivity of multiparametric MRI for clinically significant prostate cancer in men under the age of 50
por: Gielchinsky, Ilan, et al.
Publicado: (2018)

The clinical utility of transperineal template-guided saturation prostate biopsy for risk stratification after transrectal ultrasound-guided biopsy
por: Song, Wan, et al.
Publicado: (2019)

Personalised biopsy schedules based on risk of Gleason upgrading for patients with low‐risk prostate cancer on active surveillance
por: Tomer, Anirudh, et al.
Publicado: (2020)

The Patient Journey from Randomization to Detection of Prostate Cancer and Death: Results from ERSPC Rotterdam
por: Remmers, Sebastiaan, et al.
Publicado: (2023)

Transperineal prostate biopsy: a review of technique
por: Thomson, Alice, et al.
Publicado: (2020)

Comparison of biopsy under‐sampling and annual progression using hidden markov models to learn from prostate cancer active surveillance studies
por: Li, Weiyu, et al.
Publicado: (2020)

Transperineal template-guided saturation biopsy aimed at sampling one core for each milliliter of prostate volume: 103 cases requiring repeat prostate biopsy
por: Nakai, Yasushi, et al.
Publicado: (2017)

Repeat Prostate Biopsy Strategies after Initial Negative Biopsy: Meta-Regression Comparing Cancer Detection of Transperineal, Transrectal Saturation and MRI Guided Biopsy
por: Nelson, Adam W., et al.
Publicado: (2013)

p53 nuclear accumulation as an early indicator of lethal prostate cancer
por: Quinn, David I., et al.
Publicado: (2019)

Pooled outcomes of performing freehand transperineal prostate biopsy with the PrecisionPoint Transperineal Access System
por: Tzeng, Michael, et al.
Publicado: (2022)

A Tool for Shared Decision Making on Referral for Prostate Biopsy in the Primary Care Setting: Integrating Risks of Cancer with Life Expectancy
por: Verbeek, Jan F.M., et al.
Publicado: (2019)

BiopSee(®) – transperineal stereotactic navigated prostate biopsy
por: Zogal, Pawel, et al.
Publicado: (2011)

Rebiopsy rate after transperineal or transrectal prostate biopsy
por: Marenco Jimenez, Jose L., et al.
Publicado: (2021)

Template guided transperineal saturation biopsy of the prostate: lessons for focal and urethra-sparing high-dose-rate brachytherapy for localized prostate cancer
por: Novikov, Sergey Nikolaevich, et al.
Publicado: (2016)

Updating the Rotterdam Prostate Cancer Risk Calculator with Invasive Cribriform and/or Intraductal Carcinoma for Men with a Prior Negative Biopsy
por: Remmers, Sebastiaan, et al.
Publicado: (2021)

Computational imaging reveals shape differences between normal and malignant prostates on MRI
por: Rusu, Mirabela, et al.
Publicado: (2017)

Personalized schedules for surveillance of low‐risk prostate cancer patients
por: Tomer, Anirudh, et al.
Publicado: (2018)

Continued administration of antithrombotic agents during transperineal prostate biopsy
por: Asano, Toko, et al.
Publicado: (2015)

Predictors of erectile dysfunction after transperineal template prostate biopsy
por: Tan, Jo-Lynn, et al.
Publicado: (2021)

Combination of Peri-Tumoral and Intra-Tumoral Radiomic Features on Bi-Parametric MRI Accurately Stratifies Prostate Cancer Risk: A Multi-Site Study
por: Algohary, Ahmad, et al.
Publicado: (2020)

Salvage robot-assisted radical prostatectomy following focal ablation with irreversible electroporation: feasibility, oncological and functional outcomes
por: Blazevski, Alexandar, et al.
Publicado: (2022)

Identifying the morphologic basis for radiomic features in distinguishing different Gleason grades of prostate cancer on MRI: Preliminary findings
por: Penzias, Gregory, et al.
Publicado: (2018)

A Novel Risk Calculator Incorporating Clinical Parameters, Multiparametric Magnetic Resonance Imaging, and Prostate-Specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Risk Stratification Before Transperineal Prostate Biopsy
por: Kelly, Brian D., et al.
Publicado: (2023)

CT-PLANNED transperineal prostate BIOPSY IN patients without a rectum
por: Merrick, Gregory S., et al.
Publicado: (2020)

Transperineal ultrasound-guided prostate biopsy: what the radiologist needs to know
por: Power, Jack, et al.
Publicado: (2022)

Hair embedding after transperineal prostate biopsy: two case reports
por: Ni, Jiaxuan, et al.
Publicado: (2023)

Transperineal Prostate Biopsy Targeted by Magnetic Resonance Imaging Cognitive Fusion
por: Drăgoescu, Petru Octavian, et al.
Publicado: (2023)

(68)Ga-PSMA-PET/CT in addition to mpMRI in men undergoing biopsy during active surveillance for low- to intermediate-risk prostate cancer: study protocol for a prospective cross-sectional study
por: Gondoputro, William, et al.
Publicado: (2023)

Analysis of prostate cancer localization toward improved diagnostic accuracy of transperineal prostate biopsy
por: Sakamoto, Yoshiro, et al.
Publicado: (2014)

Affordable novel device (VY) for transperineal prostate biopsy: A trial on prostate mannequin
por: Pramod, Sawkar Vijay, et al.
Publicado: (2021)

Comparison of the complications of traditional 12 cores transrectal prostate biopsy with image fusion guided transperineal prostate biopsy
por: Huang, Haifeng, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_lola0h1kt3l3fbo4u18co4isai